-
公开(公告)号:USD612931S1
公开(公告)日:2010-03-30
申请号:US29343359
申请日:2009-09-11
-
公开(公告)号:USD612927S1
公开(公告)日:2010-03-30
申请号:US29343353
申请日:2009-09-11
-
公开(公告)号:US20110056501A1
公开(公告)日:2011-03-10
申请号:US12935953
申请日:2009-04-01
申请人: Pirjo Kortesuo , Ulla Calvo Alonso , Pirjo Inki , Harri Jukarainen , Ilkka Jutila , Juha Lehtinen , Eeva Lukkari-Lax , Heikki Lyytikäinen , Joachim Moede , Hannu Nikander , Pirjo Sallinen , Taina Tjäder , Andrew Macleod , Michael Noble , David Whitaker
发明人: Pirjo Kortesuo , Ulla Calvo Alonso , Pirjo Inki , Harri Jukarainen , Ilkka Jutila , Juha Lehtinen , Eeva Lukkari-Lax , Heikki Lyytikäinen , Joachim Moede , Hannu Nikander , Pirjo Sallinen , Taina Tjäder , Andrew Macleod , Michael Noble , David Whitaker
CPC分类号: A61F6/142 , A61B34/20 , A61B90/39 , A61B2034/2065 , A61F6/18
摘要: The present invention relates to novel intrauterine systems and to methods for manufacturing these systems. An intrauterine system according to the invention comprises a reservoir and a continuous, closed and flexible frame.
摘要翻译: 本发明涉及新颖的子宫内系统和用于制造这些系统的方法。 根据本发明的子宫内系统包括储存器和连续的,封闭且柔性的框架。
-
公开(公告)号:US20090142313A1
公开(公告)日:2009-06-04
申请号:US12275115
申请日:2008-11-20
IPC分类号: A61K31/585 , A61P31/04 , A61P31/10 , A61K35/74
CPC分类号: A61K31/56 , A61K9/0036 , A61K31/565 , A61K31/585 , A61K2300/00
摘要: The present invention is related to an intravaginal delivery system for the controlled release of drospirenone and an estrogen, optionally also comprising one or more therapeutically active or a health-promoting substance capable of giving and/or enhancing protection against bacterial and fungal infections, and/or enhancing protection against sexually transmitted diseases. The delivery system consists of one or more compartments, one of each comprising a core and a membrane encasing the core, said core and membrane essentially consisting of a same or different polymer composition, wherein at least one compartment comprises drospirenone ant at least one compartment which may be the same or different from the one comprising drospirenone, comprises an estrogen or a mixture of drospirenone and an estrogen, and wherein the membrane or the surface of the membrane or at least one of the cores comprises said therapeutically active or a health-promoting substance.
摘要翻译: 本发明涉及用于控制释放屈螺酮和雌激素的阴道内递送系统,任选地还包含一种或多种治疗活性或健康促进物质,其能够产生和/或增强针对细菌和真菌感染的保护和/ 或加强对性传播疾病的保护。 递送系统由一个或多个隔室组成,每个隔室中的一个包括芯和包围芯的膜,所述芯和膜基本上由相同或不同的聚合物组合物组成,其中至少一个隔室包含屈螺酮蚂蚁至少一个隔室, 可以与包含屈螺酮的那些相同或不同,包括雌激素或屈螺酮和雌激素的混合物,并且其中膜或膜的表面或至少一个核包含所述治疗活性或健康促进作用 物质。
-
公开(公告)号:US6083938A
公开(公告)日:2000-07-04
申请号:US219692
申请日:1998-12-23
申请人: Marjaana Heikkila-Hoikka , Hannu Nikander , Ritva Hannuniemi , Leena Lauren , Terttu Kleimola , Sirpa Liukko-Sipi , Kalervo Vaananen , Raija Sellman
发明人: Marjaana Heikkila-Hoikka , Hannu Nikander , Ritva Hannuniemi , Leena Lauren , Terttu Kleimola , Sirpa Liukko-Sipi , Kalervo Vaananen , Raija Sellman
IPC分类号: A61K31/675 , A61K20060101 , A61K9/107 , A61K31/575 , A61K31/66 , A61K31/663 , A61P3/02 , A61P19/00 , A61P19/08 , A61P19/10 , A61P43/00 , C07D213/72 , C07F9/58
CPC分类号: A61K31/683 , A61K31/675
摘要: The present invention relates to certain optionally ring substituted pyridinylaminomethylidene bisophosphonic acid tetralkyl esters (I) and their use for the treatment of bone diseases, such as osteolytic bone diseases due to malignancy, Paget's disease and primary and secondary osteoporosis.
摘要翻译: 本发明涉及某些任选环取代的吡啶基氨基亚甲基双膦酸四烷基酯(I)及其用于治疗由于恶性肿瘤引起的溶骨性骨疾病,佩吉特氏病和原发性和继发性骨质疏松症等骨骼疾病的用途。
-
公开(公告)号:US5866556A
公开(公告)日:1999-02-02
申请号:US750355
申请日:1996-12-06
申请人: Marjaana Heikkila-Hoikka , Hannu Nikander , Ritva Hannuniemi , Leena Lauren , Terttu Kleimola , Sirpa Liukko-Sipi , Kalervo Vaananen , Raija Sellman
发明人: Marjaana Heikkila-Hoikka , Hannu Nikander , Ritva Hannuniemi , Leena Lauren , Terttu Kleimola , Sirpa Liukko-Sipi , Kalervo Vaananen , Raija Sellman
IPC分类号: A61K31/675 , A61K20060101 , A61K9/107 , A61K31/575 , A61K31/66 , A61K31/663 , A61P3/02 , A61P19/00 , A61P19/08 , A61P19/10 , A61P43/00 , C07D213/72 , C07F9/58
CPC分类号: A61K31/683 , A61K31/675
摘要: The present invention relates to certain optionally ring substituted pyridinylaminomethylidene bisphosphonic acid tetralkyl esters (I) and their use for the treatment of bone diseases, such as osteolytic bone diseases due to malignancy, Paget's disease and primary and secondary osteoporosis.
摘要翻译: PCT No.PCT / FI95 / 00315 Sec。 371日期1996年12月6日第 102(e)日期1996年12月6日PCT归档1995年6月2日PCT公布。 公开号WO95 / 33466 日期1995年12月14日本发明涉及某些任选环取代的吡啶基氨基亚甲基双膦酸四烷基酯(I)及其用于治疗由于恶性肿瘤引起的溶骨性骨疾病,佩吉特氏病和原发性和继发性骨质疏松症等骨疾病的用途。
-
-
-
-
-